SUBSCRIBE
SUBSCRIBE

Phase I

Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Business
This Small Massachusetts Biotech Soared to a 20-Month High on Its Celgene-Partnered Trial
June 7, 2017
 · 
2 min read
Bristol-Myers Squibb's Stock Topples as Kidney Cancer Drug Flunks Phase III Study
Drug Development
Bristol-Myers Squibb Loses $4.3 Billion in Market Value After ASCO Update
June 7, 2017
 · 
3 min read
Drug Development
A Small Drugmaker Is Taking An Entirely New Approach To Getting Its Cancer Drug Approved
June 6, 2017
 · 
1 min read
Down but Not Out, Juno Fights Back with Positive CAR-T Results in its JCAR017 Program
Drug Development
Down but Not Out, Juno Fights Back with Positive CAR-T Results in its JCAR017 Program
June 5, 2017
 · 
2 min read
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Drug Development
Investors Sigh With Relief as bluebird bio, Celgene’s CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free
June 5, 2017
 · 
3 min read
Biotech Startups Flock to the Suburbs Over Rising Rent Prices
Drug Development
Unknown Nanjing Legend Emerges as a CAR-T Phenom at ASCO
June 5, 2017
 · 
3 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Drug Development
Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It
June 5, 2017
 · 
3 min read
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Drug Development
Stock Tanks as Endocyte Cuts 40% of Workforce, Slashes 2 Clinical Programs
June 2, 2017
 · 
3 min read
Exiting Novartis AG CEO Sets His Sights on Silicon Valley and Its Biotech Startups
Drug Development
Novartis AG Lays Out R&D Game Plan at Meet and Greet With 30 Execs in Boston
June 1, 2017
 · 
3 min read
Gilead Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency
Drug Development
A Look at Gilead’s Possible New Drug Strategy
May 31, 2017
 · 
3 min read
Load More
PRESS RELEASES
Drug Development
IN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual Meeting
June 5, 2023
 · 
7 min read
Drug Development
NovelMed Phase I Clinical Trial Shows Inhibition of the Alternative Pathway and Preservation of the Classical Pathway – A Long-Acting Anti-Properdin Monoclonal Antibody NM3086 for PNH Patients
June 5, 2023
 · 
6 min read
Drug Development
Enterin Announces the Start of a First-in-Human Study of ENT-03 in Obesity and Type 2 Diabetes
June 5, 2023
 · 
2 min read
Business
Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced MCC and Cutaneous Squamous Cell Carcinoma (cSCC)
June 5, 2023
 · 
12 min read
Drug Development
Amolyt Pharma Announces Initiation of Phase 1 Clinical Trial of Peptide Growth Hormone Receptor Antagonist (GHRA), AZP-3813, for Acromegaly
June 5, 2023
 · 
3 min read
Drug Development
Immuneering Completes Dose Escalation in the IMM-1-104 Phase 1 Clinical Trial for RAS-Mutant, Advanced Solid Tumors
June 5, 2023
 · 
5 min read
Drug Development
Walden Biosciences Announces First Subject Dosed in First-in-Humans Phase 1 Clinical Trial of WAL0921, in Development for Treatment of Chronic Kidney Diseases
June 5, 2023
 · 
3 min read
Drug Development
Dr. Reddy’s Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab
June 5, 2023
 · 
6 min read
Drug Development
Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in DMT Phase 1 Trial; Accelerates Plans for Phase 2 Stroke and TBI Studies
June 5, 2023
 · 
6 min read
Drug Development
Foghorn Therapeutics Announces FDA Has Lifted Clinical Hold on Phase 1 Study of FHD-286 in Relapsed and/or Refractory AML/MDS Patients
June 5, 2023
 · 
8 min read
Drug Development
Sirnaomics Reports Interim Results of STP705 Phase I Clinical Study for Medical Aesthetics Treatment in Adults Undergoing Abdominoplasty
June 5, 2023
 · 
6 min read
Drug Development
Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
June 5, 2023
 · 
3 min read
Drug Development
Harbour BioMed Announces First Patient Dosed in Phase I Study of First-in-Class Anti-B7H7 (HHLA2) Antibody HBM1020
June 4, 2023
 · 
4 min read
Drug Development
Chimeric Announces Launch of New Phase 1B Glioblastoma Clinical Trial
June 4, 2023
 · 
5 min read
Drug Development
VITRAC Therapeutics to Present Phase 1 Clinical Trial Design on Novel Aurora Kinase A Inhibitor, VIC-1911, and G12C Inhibitor, Sotorasib, for KRAS G12C-Mutant Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting
June 4, 2023
 · 
2 min read
Drug Development
Innovent Presents Phase 1b Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2023 ASCO Annual Meeting
June 4, 2023
 · 
9 min read
Drug Development
Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting
June 3, 2023
 · 
7 min read
Drug Development
Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial
June 3, 2023
 · 
5 min read
Drug Development
Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1
June 3, 2023
 · 
7 min read
Drug Development
Janssen Presents Longer-Term Talquetamab Follow-Up Data Showing Overall Response Rates of More Than 70 Percent in Heavily Pretreated Patients with Multiple Myeloma
June 3, 2023
 · 
25 min read
Load More